Skip to main content

Articles

3909 result(s) for 'lung cancer prognosis stage 4' within BMC Cancer

Page 27 of 79

  1. Early screening and intervention therapies are crucial to improve the prognosis of hepatocellular carcinoma (HCC) patients with bone metastasis. We aimed to identify serum lncRNA as a prediction biomarker in H...

    Authors: Li Zhang, Hao Niu, Ping Yang, Jie Ma, Bao-Ying Yuan, Zhao-Chong Zeng and Zuo-Lin Xiang
    Citation: BMC Cancer 2021 21:161
    Content type: Research article Published on:

  2. The associations with cancer and cardiovascular diseases (CVD) had inconsistent results. The study aimed to investigate the risk of cardiovascular diseases (CVD) between populations with and without cancer.

    Authors: Tzu-Lin Yeh, Min-Shu Hsu, Hsin-Yin Hsu, Ming-Chieh Tsai, Jing-Rong Jhuang, Chun-Ju Chiang, Wen-Chung Lee and Kuo-Liong Chien
    Citation: BMC Cancer 2022 22:1198
    Content type: Research Published on:

  3. IL-17A is a pro-inflammatory cytokine that is normally associated with autoimmune arthritis and other pro-inflammatory conditions. Recently, IL-17A has emerged as a critical factor in enhancing breast cancer (...

    Authors: Lopamudra Das Roy, Mahnaz Sahraei, Jorge L Schettini, Helen E Gruber, Dahlia M Besmer and Pinku Mukherjee
    Citation: BMC Cancer 2014 14:225
    Content type: Research article Published on:

  4. Matrix metalloproteases and collagen are key participants in breast cancer, but their precise roles in cancer etiology and progression remain unclear. MMP13 helps regulate collagen structure and has been ascri...

    Authors: Seth W Perry, Jill M Schueckler, Kathleen Burke, Giuseppe L Arcuri and Edward B Brown
    Citation: BMC Cancer 2013 13:411
    Content type: Research article Published on:

  5. Increasing evidence indicates that abnormal expression of GABPA is associated with tumor development and progression. However, the function and clinicopathological significance of GABPA in hepatocellular carci...

    Authors: Sheng Zhang, Kang Zhang, Piyou Ji, Xuqing Zheng, Jianbin Jin, Min Feng and Pingguo Liu
    Citation: BMC Cancer 2017 17:380
    Content type: Research article Published on:

  6. Although criteria for liver transplantation, such as the Milan criteria and Hangzhou experiences, have become popular, criteria to guide adjuvant therapy for patients with hepatocellular carcinoma after liver ...

    Authors: Dabing Huang, Yinan Shen, Wei Zhang, Chengxiang Guo, Tingbo Liang and Xueli Bai
    Citation: BMC Cancer 2021 21:280
    Content type: Research article Published on:

  7. Although postoperative chemotherapy is widely accepted as the standard modality for Dukes' stage C or earlier stage colorectal cancer (CRC) patients, biomarkers to predict those who may benefit from the therap...

    Authors: Ten-i Godai, Tetsuji Suda, Nobuhiro Sugano, Kazuhito Tsuchida, Manabu Shiozawa, Hironobu Sekiguchi, Akiko Sekiyama, Mitsuyo Yoshihara, Shoichi Matsukuma, Yuji Sakuma, Eiju Tsuchiya, Yoichi Kameda, Makoto Akaike and Yohei Miyagi
    Citation: BMC Cancer 2009 9:420
    Content type: Research article Published on:

  8. Extremity liposarcoma represents 25% of extremity soft tissue sarcoma and has a better prognosis than liposarcoma occurring in other anatomic sites. The purpose of this study was to develop two nomograms for p...

    Authors: Lin Ye, Chuan Hu, Cailin Wang, Weiyang Yu, Feijun Liu and Zhenzhong Chen
    Citation: BMC Cancer 2020 20:889
    Content type: Research article Published on:

  9. Early recurrence is the major cause of poor prognosis in hepatocellular carcinoma (HCC). Long non-coding RNAs (lncRNAs) are deeply involved in HCC prognosis. In this study, we aimed to establish a prognostic l...

    Authors: Yi Fu, Xindong Wei, Qiuqin Han, Jiamei Le, Yujie Ma, Xinjie Lin, Yuhui Xu, Ning Liu, Xuan Wang, Xiaoni Kong, Jinyang Gu, Ying Tong and Hailong Wu
    Citation: BMC Cancer 2021 21:1165
    Content type: Research Published on:

  10. The objective of our study was to investigate the clinical characteristics and prognosis of postterm choriocarcinoma patients at Peking Union Medical College Hospital within the past 30 years.

    Authors: Jie Li, Junjun Yang, Pengfei Liu, Tong Ren, Jun Zhao, Fengzhi Feng, Xirun Wan and Yang Xiang
    Citation: BMC Cancer 2016 16:347
    Content type: Research article Published on:

  12. Dickkopf-1 (DKK1) is a Wnt/ß-catenin pathway antagonist related to gastric cancer (GC) carcinogenesis. However, the prognostic role of combined DKK1 and ß-catenin expression in advanced GC (AGC) is not clear.

    Authors: Soon Auck Hong, Su Hyun Yoo, Han Hong Lee, Der Sheng Sun, Hye Sung Won, Okran Kim and Yoon Ho Ko
    Citation: BMC Cancer 2018 18:506
    Content type: Research article Published on:

  13. Most patients with ovarian cancer are diagnosed with advanced stage disease (i.e., stage III-IV), which is associated with a poor prognosis. Differentially expressed genes (DEGs) in stage III serous ovarian carci...

    Authors: Yun-Sook Kim, Jin Hwan Do, Sumi Bae, Dong-Han Bae and Woong Shick Ahn
    Citation: BMC Cancer 2010 10:576
    Content type: Research article Published on:

  14. Lymph node (LN) status is a key prognostic factor in the decision-making process of different cancer entities, including prostate cancer (PCa). Sectioning and haematoxylin and eosin (H&E) staining technique re...

    Authors: Mercè Cuadras, Jacques Planas, Ana Celma, Lucas Regis, Inés M. de Torres, M. Eugenia Semidey, Enrique Trilla and Juan Morote
    Citation: BMC Cancer 2022 22:357
    Content type: Research Published on:

  15. Breast cancer metastasis suppressor 1 (BRMS1) is a metastasis suppressor gene. This study aimed to investigate the impact of BRMS1 on metastasis in nasopharyngeal carcinoma (NPC) and to evaluate the prognostic...

    Authors: Rui-Xue Cui, Na Liu, Qing-Mei He, Wen-Fei Li, Bi-Jun Huang, Ying Sun, Ling-Long Tang, Mo Chen, Ning Jiang, Lei Chen, Jing-Ping Yun, Jing Zeng, Ying Guo, Hui-Yun Wang and Jun Ma
    Citation: BMC Cancer 2012 12:376
    Content type: Research article Published on:

  16. The NEK serine/threonine protein kinases are involved in cell cycle checkpoints, DNA damage repair, and apoptosis. Alterations in these pathways are frequently associated with cell malignant cellular transform...

    Authors: Talita Diniz Melo-Hanchuk, Mariana Bonjiorno Martins, Lucas Leite Cunha, Fernando Augusto Soares, Laura Sterian Ward, José Vassallo and Jörg Kobarg
    Citation: BMC Cancer 2020 20:23
    Content type: Research article Published on:

  18. The survival rate of patients with advanced oesophageal cancer is very low and can vary significantly, even among patients with the same TNM stage. It is important to look for indicators that are economical an...

    Authors: Ke-Jie Li, Xiao-Fang Xia, Meng Su, Hui Zhang, Wen-Hao Chen and Chang-Lin Zou
    Citation: BMC Cancer 2019 19:1004
    Content type: Research article Published on:

  19. The early detection of synchronous bone metastasis (BM) in newly diagnosed colorectal cancer (CRC) affects its initial management and prognosis. A clinical model to individually predict the risk of developing ...

    Authors: Xu Guan, Chen-xi Ma, Ji-chuan Quan, Shuai Li, Zhi-xun Zhao, Hai-peng Chen, Ming Yang, Zheng Liu, Zheng Jiang and Xi-shan Wang
    Citation: BMC Cancer 2019 19:704
    Content type: Research article Published on:

  20. Patients suffering from high risk stage II colon cancer (CC) may benefit from adjuvant onco-therapy, but additional prognostic markers are needed for better treatment stratification. We investigated the progno...

    Authors: Ann C. Eriksen, Flemming B. Sørensen, Jan Lindebjerg, Henrik Hager, René dePont Christensen, Sanne Kjær-Frifeldt and Torben F. Hansen
    Citation: BMC Cancer 2019 19:142
    Content type: Research article Published on:

  23. Hepatocellular carcinoma (HCC) is a malignant tumor that threatens global human health. High PKM2 expression is widely reported in multiple cancers, especially in HCC. This study aimed to explore the effects o...

    Authors: Wen-Wen Lv, Dahai Liu, Xing-Cun Liu, Tie-Nan Feng, Lei Li, Bi-Yun Qian and Wen-Xing Li
    Citation: BMC Cancer 2018 18:1150
    Content type: Research article Published on:

  24. Endocrine therapy (ET)-based regimens are the mainstay of treatment for patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2−) advanced breast cancer. With the in...

    Authors: Alison Davie, Gebra Cuyun Carter, Alex Rider, James Pike, Katie Lewis, Abigail Bailey, Gregory L. Price, Francois Ringeisen and Xavier Pivot
    Citation: BMC Cancer 2020 20:855
    Content type: Research article Published on:

  25. Breast cancer (BC) patients tend to suffer from distant metastasis, especially bone metastasis.

    Authors: Kang Yao, Zhu Xiaojun, Zhao Tingxiao, Liao Shiyao, Ji Lichen, Zhang Wei, Li Yanlei, Tian Jinlong, Ding Xiaoyan, Zhang Jun, Bi Qing and Lv Jun
    Citation: BMC Cancer 2023 23:1213
    Content type: Research Published on:

    The Correction to this article has been published in BMC Cancer 2023 23:1265

  27. Findings from numerous studies have revealed that ferroptosis is closely related to tumorigenesis and immune cell infiltration. Long non-coding RNAs (lncRNAs) are reportedly involved in the progression of vari...

    Authors: Chunhui Liu, Yue Gao, Jiaxuan Ni, Saisai Chen, Qiang Hu, Can Wang, Mingjin Hu and Ming Chen
    Citation: BMC Cancer 2022 22:788
    Content type: Research Published on:

  28. Recent advances have shown that histology and genetic biomarkers are important in patient selection, which have led to significantly better outcomes for lung cancer patients. However, most new treatments only ...

    Authors: Jin-Ji Yang, Cheng Huang, Gong-Yan Chen, Yong Song, Ying Cheng, Hong-Hong Yan, Qing Zhou and Yi-Long Wu
    Citation: BMC Cancer 2014 14:684
    Content type: Study protocol Published on:

  29. F-18- fluorodeoxyglucose Positron emission tomography (18FDG-PET) has been widely used in clinical practice. However, the prognostic value of the pretreatment standardized uptake value (SUV) for patients with gas...

    Authors: Zhonghua Wu, Junhua Zhao, Peng Gao, Yongxi Song, Jingxu Sun, Xiaowan Chen, Bin Ma and Zhenning Wang
    Citation: BMC Cancer 2017 17:275
    Content type: Research article Published on:

  30. Our study aims to evaluate the expression of TLR9 in glioma tissues, examine the association between TLR9 expression, clinicopathological variables, and glioma patient outcome, we further characterized the dir...

    Authors: Chao Wang, Shouqiang Cao, Ying Yan, Qiao Ying, Tao Jiang, Ke Xu and Anhua Wu
    Citation: BMC Cancer 2010 10:415
    Content type: Research article Published on:

  31. Residual breast cancer after neo-adjuvant chemotherapy (NACT) predicts disease outcome and is a surrogate for survival in aggressive breast cancer (BC) subtypes. Pathological complete response (pCR) rate, howe...

    Authors: Alex De Caluwé, Laurence Buisseret, Philip Poortmans, Dirk Van Gestel, Roberto Salgado, Christos Sotiriou, Denis Larsimont, Marianne Paesmans, Ligia Craciun, Drisis Stylianos, Christophe Vandekerckhove, Fabien Reyal, Veys Isabelle, Daniel Eiger, Martine Piccart, Emanuela Romano…
    Citation: BMC Cancer 2021 21:899
    Content type: Study protocol Published on:

  32. The number of young patients with hepatocellular carcinoma (HCC) is increasing, but whether patients of different ages have a survival advantage is unclear. This study was conducted to investigate whether age ...

    Authors: Huiwen Yan, Xinhui Wang, Xiaoli Liu, Peng Wang, Lihua Yu, Dongdong Zhou and Zhiyun Yang
    Citation: BMC Cancer 2022 22:185
    Content type: Research Published on:

  33. We previously reported the synergistic effect of S-1 and eribulin in preclinical models. In addition, our phase I study revealed the recommended dose for the phase II study of the combination therapy in advanc...

    Authors: Tsutomu Iwasa, Junji Tsurutani, Satomi Watanabe, Ryoji Kato, Yutaka Mizuno, Yasuyuki Kojima, Tsutomu Takashima, Nobuki Matsunami, Takashi Morimoto, Jun Yamamura, Shoichiro Ohtani, Yuko Tanabe, Tetsuhiro Yoshinami, Toshimi Takano, Yoshifumi Komoike and Kazuhiko Nakagawa
    Citation: BMC Cancer 2019 19:962
    Content type: Research article Published on:

  34. The aim of the study is to explore the role of preoperative folate receptor-positive circulating tumor cell (FR+CTC) levels in predicting disease-free survival (DFS) and overall survival (OS) in patients with eso...

    Authors: Qiang Zhou, Qiao He, Wenwu He, Chenghao Wang, Guangyuan Liu, Kangning Wang, Haojun Li, Jialong Li, Wenguang Xiao, Qiang Fang, Lin Peng, Yongtao Han, Dongsheng Wang and Xuefeng Leng
    Citation: BMC Cancer 2023 23:1171
    Content type: Research Published on:

  35. Accumulating evidence has revealed that the gut microbiota influences the effectiveness of immune checkpoint inhibitors (ICIs) in cancer patients. As a part of the human microbiome, Helicobacter pylori (H. pylori...

    Authors: Hebin Che, Qi Xiong, Jinxia Ma, Shixue Chen, Huan Wu, Hongli Xu and Baicun Hou
    Citation: BMC Cancer 2022 22:904
    Content type: Research Published on:

  36. The study was to investigate whether 18F-fluorodeoxyglucose (18F-FDG) uptake, analyzed by positron emission tomography (PET), can be used preoperatively to predict survival in Chinese patients with colorectal car...

    Authors: Debing Shi, Guoxiang Cai, Junjie Peng, Dawei Li, Xinxiang Li, Ye Xu and Sanjun Cai
    Citation: BMC Cancer 2015 15:991
    Content type: Research article Published on:

  37. The adverse reactions (ADRs) of targeted therapy were closely associated with treatment response, clinical outcome, quality of life (QoL) of patients with cancer. However, few studies presented the correlation...

    Authors: Ruofei Du, Xin Wang, Lixia Ma, Leon M. Larcher, Han Tang, Huiyue Zhou, Changying Chen and Tao Wang
    Citation: BMC Cancer 2021 21:206
    Content type: Research article Published on:

  38. C5aR has been extensively studied in recent years as an essential component of the complement system. However, the role of C5aR in tumors has not been sufficiently investigated and summarized. The aim of this ...

    Authors: Ziran Wang, Wenwei Yu, Yawen Qiang, Fan Ma, Pengsheng Ding and Yangyan Wang
    Citation: BMC Cancer 2021 21:1136
    Content type: Research Published on:

  39. RAI3 is an orphan G-protein coupled receptor (GPCR) that has been associated with malignancy and may play a role in the proliferation of breast cancer cells. Although its exact function in normal and malignant...

    Authors: Hannah Jörißen, Nuran Bektas, Edgar Dahl, Arndt Hartmann, Anette ten Haaf, Stefano Di Fiore, Hans Kiefer, Andreas Thess, Stefan Barth and Torsten Klockenbring
    Citation: BMC Cancer 2009 9:200
    Content type: Technical advance Published on:

  40. Interleukin-1 receptor antagonist (IL1RN) has been reported as a biomarker of many cancers. However, the biological function of IL1RN in papillary thyroid carcinoma (PTC) remains undetermined.

    Authors: Zhenyu Xie, Xin Li, Yuzhen He, Song Wu, Shiyue Wang, Jianjian Sun, Yuchen He, Yu Lun, Shijie Xin and Jian Zhang
    Citation: BMC Cancer 2020 20:1143
    Content type: Research article Published on:

  41. The purpose of this retrospective study was to determine whether RFA could provide an alternative treatment modality for selected patients who are not candidates for hepatic resection.

    Authors: Jin Won Lee, Moon Hyung Choi, Young Joon Lee, Bandar Ali, Han Mo Yoo, Kyo Young Song and Cho Hyun Park
    Citation: BMC Cancer 2017 17:185
    Content type: Research article Published on:

  42. The role of nicotinamide N-methyltransferase (NNMT) in ovarian cancer is still elusive. Our aim is to explore the expression of NNMT in ovarian cancer and to assess its association with patient prognosis and t...

    Authors: Jun Li, Huiran Yue, Hailin Yu, Xin Lu and Xiaohong Xue
    Citation: BMC Cancer 2021 21:67
    Content type: Research article Published on:

  43. Lung adenocarcinoma patients with EGFR gene mutations have shown a dramatic response to gefitinib. However, drug resistance eventually emerges which limits the mean duration of response. With that in view, we exa...

    Authors: Rintaro Noro, Masahiro Seike, Fenfei Zou, Chie Soeno, Kuniko Matsuda, Teppei Sugano, Nobuhiko Nishijima, Masaru Matsumoto, Kazuhiro Kitamura, Seiji Kosaihira, Yuji Minegishi, Akinobu Yoshimura, Kaoru Kubota and Akihiko Gemma
    Citation: BMC Cancer 2015 15:31
    Content type: Research article Published on:

  44. N-myc downstream-regulated gene-1 (NDRG1) is well-described as a potent metastasis suppressor, but its role in human breast cancer remains controversial and unclear. Therefore, the present study utilized a sys...

    Authors: Kwuntida Kotepui, Manas Kotepui, Hideyuki J. Majima and Jitbanjong Tangpong
    Citation: BMC Cancer 2023 23:1003
    Content type: Research Published on:

  45. Little is known about whether age at initial diagnosis influences the prognosis of recurrent metastatic breast cancer (rMBC). Here, we analyzed the association between age at initial diagnosis and rMBC mortali...

    Authors: Yuxin Xie, Qiheng Gou, Yingjie Zhang, Keqi Xie, Dan Zheng, Chuanxu Luo, Jiaojiao Suo, Xiaorong Zhong and Ting Luo
    Citation: BMC Cancer 2022 22:385
    Content type: Research Published on:

  46. To evaluate the clinicopathological and prognostic significance of the percentage change between maximum standardized uptake value (SUVmax) at 60 min (SUVmax1) and SUVmax at 120 min (SUVmax2) (ΔSUVmax%) using dua...

    Authors: Yoji YAMAGISHI, Tomomi KOIWAI, Tamio YAMASAKI, Takahiro EINAMA, Makiko FUKUMURA, Miyuki HIRATSUKA, Takako KONO, Katsumi HAYASHI, Jiro ISHIDA, Hideki UENO and Hitoshi TSUDA
    Citation: BMC Cancer 2019 19:1146
    Content type: Research article Published on:

  47. Vascular endothelial growth factor (VEGF) is a potent mitogen for endothelial cells, and its expression has been correlated with increased tumour angiogenesis. Although numerous publications dealing with the m...

    Authors: Ratchada Cressey, Onusa Wattananupong, Nirush Lertprasertsuke and Usanee Vinitketkumnuen
    Citation: BMC Cancer 2005 5:128
    Content type: Research article Published on:

  48. As the dominant component of the tumor microenvironment, cancer-associated fibroblasts (CAFs), play a vital role in tumor progression. An increasing number of studies have confirmed that CAFs are involved in a...

    Authors: Zhiyang Zhou, Sixuan Guo, Shuhui Lai, Tao Wang, Yao Du, Junping Deng, Shun Zhang, Ge Gao and Jiangnan Zhang
    Citation: BMC Cancer 2023 23:108
    Content type: Research Published on:

  49. In many malignancies including ovarian cancer, different angiogenic factors have been related to poor prognosis. However, data on their relations to each other or importance as a prognostic factor in ovarian c...

    Authors: Minna Sopo, Maarit Anttila, Kirsi Hämäläinen, Annukka Kivelä, Seppo Ylä-Herttuala, Veli-Matti Kosma, Leea Keski-Nisula and Hanna Sallinen
    Citation: BMC Cancer 2019 19:584
    Content type: Research article Published on:

  50. Traditional prognostic factors in epithelial ovarian cancer (EOC) are inadequate in predicting recurrence and long-term prognosis, but genome-wide cancer research has recently provided multiple potentially use...

    Authors: Renata A Tassi, Stefano Calza, Antonella Ravaggi, Eliana Bignotti, Franco E Odicino, Germana Tognon, Carla Donzelli, Marcella Falchetti, Elisa Rossi, Paola Todeschini, Chiara Romani, Elisabetta Bandiera, Laura Zanotti, Sergio Pecorelli and Alessandro D Santin
    Citation: BMC Cancer 2009 9:253
    Content type: Research article Published on:

Featured videos

View featured videos from across the BMC-series journals

Submit manuscript

Follow

BMC Cancer

ISSN: 1471-2407

Contact us